COVID-19 asymptomatic b/ts-DMARD-treated patients had lower frequencies of TH1, CD8+ CD27+ GZMB/K+, and memory B IgG+ cells (Supplementary Figures 7A–C). This evidence concerns the gene CD8A and COVID-19.